Home › Companies › CYTEK BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CYTEK BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 18, 2025: 4 items on CYTEK BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025: 2 approved · 1 passed (calculated) · 1 plurality election.
Significant dissent: 1 director (58.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CYTEK BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CYTEK BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Richard Chin, MD | 81,794,582 | -- | -- | 208,499 | 21,866,390 | 99.7% | Passed (calculated) | — |
| Elect Director: Deborah Neff | 33,819,367 | -- | -- | 48,183,714 | 21,866,390 | 41% | Plurality election | — |
| 2. Executive Compensation. On a non-binding, advisory basis, the compensation paid to the Company's named executive officers for the year ended December 31, 2024 | 76,368,883 | 5,630,057 | 4,141 | -- | 21,866,390 | 93% | Approved | — |
| 3. Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 95,862,612 | 7,657,004 | 349,855 | -- | -- | 93% | Approved | — |
Source: CYTEK BIOSCIENCES INC., Form 8-K, filed with the SEC on June 24, 2025 — read the filing on EDGAR.
See voting trends for Industrials companies, 2024-2025: shareholder support by sector and by company size.
164 asset managers disclosed a vote on at least one CYTEK BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
41% Plurality election · of votes cast
Description as filed by funds: To elect our two Class I director nominees, each to serve a three-year term, expiring at our 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Deborah Neff
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Deborah Neff”): 33,819,367 for, 48,183,714 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 41% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 7,060,272 for, 13,721,242 withheld, 13,413,653 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 12,475,286 | 0 | Abstain |
| Vanguard | 9,710 | 0 | 72 | 9,415,141 | Withhold |
| Fidelity | 2,606,140 | 0 | 0 | 50,938 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 3,251 | 0 | 0 | 1,504,786 | Withhold |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 490,680 | Withhold |
| Nationwide | 270,948 | 0 | 0 | 109,925 | Mixed |
| Equitable | 0 | 0 | 0 | 343,929 | Withhold |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 258,590 | Withhold |
| American Century | 0 | 0 | 0 | 237,682 | Withhold |
| JPMorgan | 0 | 0 | 214,445 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 209,784 | 0 | Abstain |
| Jackson National | 0 | 0 | 205,542 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 0 | 171,673 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 120,832 | Withhold |
| TIFF INVESTMENT PROGRAM | 0 | 0 | 115,896 | 0 | Abstain |
| BNY Mellon | 0 | 0 | 0 | 115,686 | Withhold |
| Prudential/PGIM | 96,257 | 0 | 0 | 17,830 | Mixed |
| Principal | 0 | 0 | 0 | 101,339 | Withhold |
| Brighthouse | 0 | 0 | 0 | 99,359 | Withhold |
| Empower | 0 | 0 | 0 | 88,987 | Withhold |
| Thrivent | 0 | 0 | 0 | 76,638 | Withhold |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect our two Class I director nominees, each to serve a three-year term, expiring at our 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Richard Chin, M.D.
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Richard Chin, MD”): 81,794,582 for, 208,499 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 34,191,253 for, 3,912 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,475,286 | 0 | 0 | 0 | For |
| Vanguard | 9,421,009 | 0 | 0 | 3,912 | For |
| Fidelity | 2,657,078 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 1,508,037 | 0 | 0 | 0 | For |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 490,680 | 0 | 0 | 0 | For |
| Nationwide | 380,873 | 0 | 0 | 0 | For |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,590 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| JPMorgan | 214,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 209,784 | 0 | 0 | 0 | For |
| Jackson National | 205,542 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 120,832 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 115,896 | 0 | 0 | 0 | For |
| BNY Mellon | 115,686 | 0 | 0 | 0 | For |
| Prudential/PGIM | 114,087 | 0 | 0 | 0 | For |
| Principal | 101,339 | 0 | 0 | 0 | For |
| Brighthouse | 99,359 | 0 | 0 | 0 | For |
| Empower | 88,987 | 0 | 0 | 0 | For |
| Thrivent | 76,638 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 85.8% for (June 5, 2024 meeting) ▲ 7.3 pts
Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS FOR THE YEAR ENDED DECEMBER 31, 2024, AS SET FORTH IN OUR PROXY STATEMENT.
CYTEK BIOSCIENCES INC.’s own tally for this item (“2. Executive Compensation. On a non-binding, advisory basis, the compensation paid to the Company's named executive officers for the year ended December 31, 2024”): 76,368,883 for, 5,630,057 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “On a non-binding, advisory basis, the compensation paid to the Company's named executive officers for the year ended December 31, 2024 was approved based on the following results of voting:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,475,286 | 0 | 0 | 0 | For |
| Vanguard | 9,421,001 | 3,921 | 0 | 0 | For |
| Fidelity | 2,657,078 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 0 | 2,054,970 | 0 | 0 | Against |
| State Street | 1,508,037 | 0 | 0 | 0 | For |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 490,680 | 0 | 0 | 0 | For |
| Nationwide | 116,364 | 264,509 | 0 | 0 | Mixed |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,590 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| JPMorgan | 214,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 209,784 | 0 | 0 | 0 | For |
| Jackson National | 205,542 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 120,832 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 115,896 | 0 | 0 | 0 | For |
| BNY Mellon | 115,686 | 0 | 0 | 0 | For |
| Prudential/PGIM | 114,087 | 0 | 0 | 0 | For |
| Principal | 101,339 | 0 | 0 | 0 | For |
| Brighthouse | 99,359 | 0 | 0 | 0 | For |
| Empower | 88,987 | 0 | 0 | 0 | For |
| Thrivent | 76,638 | 0 | 0 | 0 | For |
Fund voting reports, all 60 managers: 31,926,211 for, 2,324,428 against, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 6,657,030 | 0 | 0 | 0 | For |
| BlackRock | 4,021,725 | 0 | 0 | 0 | For |
| State Street | 3,794,194 | 0 | 0 | 0 | For |
| BROWN CAPITAL MANAGEMENT LLC | 0 | 3,530,341 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 2,711,039 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,088,390 | 0 | 0 | 0 | For |
| Charles Schwab | 1,090,607 | 0 | 0 | 0 | For |
| Northern Trust | 918,417 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 751,745 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 738,703 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 521,233 | 0 | 0 | 0 | For |
| Impresa Management LLC | 517,790 | 0 | 0 | 0 | For |
| Dimensional | 440,218 | 0 | 0 | 0 | For |
| JPMorgan | 349,004 | 0 | 0 | 0 | For |
| Nuveen | 304,985 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 290,511 | 0 | 0 | 0 | For |
| Vanguard | 276,240 | 0 | 0 | 0 | For |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 250,785 | 0 | 0 | 0 | For |
| AQR | 242,353 | 0 | 0 | 0 | For |
| Citadel | 239,872 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 236,418 | 0 | 0 | 0 | For |
| Fidelity | 201,392 | 0 | 0 | 0 | For |
| Invesco | 191,230 | 0 | 0 | 0 | For |
| Legal & General Investment Management America Inc | 0 | 179,772 | 0 | 0 | Against |
Institutional-manager reports, all 124 managers: 29,891,594 for, 4,102,672 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 97.6% for (June 5, 2024 meeting) ▼ 5.0 pts
Description as filed by funds: TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
CYTEK BIOSCIENCES INC.’s own tally for this item (“3. Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December”): 95,862,612 for, 7,657,004 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on the following results of voting:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 34,157,430 for, 37,736 against, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,475,286 | 0 | 0 | 0 | For |
| Vanguard | 9,424,915 | 7 | 0 | 0 | For |
| Fidelity | 2,657,078 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 1,507,459 | 578 | 0 | 0 | For |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 490,680 | 0 | 0 | 0 | For |
| Nationwide | 356,573 | 24,300 | 0 | 0 | Mixed |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,590 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| JPMorgan | 214,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 209,784 | 0 | 0 | 0 | For |
| Jackson National | 205,542 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 120,832 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 115,896 | 0 | 0 | 0 | For |
| BNY Mellon | 115,686 | 0 | 0 | 0 | For |
| Prudential/PGIM | 114,087 | 0 | 0 | 0 | For |
| Principal | 101,339 | 0 | 0 | 0 | For |
| Brighthouse | 99,359 | 0 | 0 | 0 | For |
| Empower | 88,987 | 0 | 0 | 0 | For |
| Thrivent | 76,638 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 126,659,196 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 9.85% |
| 2 | Vanguard | 7.44% |
| 3 | Fidelity | 2.10% |
| 4 | Brown Capital Management Mutual Funds | 1.62% |
| 5 | State Street | 1.19% |
| 6 | Charles Schwab | 0.77% |
| 7 | Royce | 0.57% |
| 8 | Goldman Sachs | 0.39% |
| 9 | Nationwide | 0.30% |
| 10 | Equitable | 0.27% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | HHLR ADVISORS, LTD. | 5.26% |
| 2 | BlackRock | 3.18% |
| 3 | State Street | 3.00% |
| 4 | BROWN CAPITAL MANAGEMENT LLC | 2.79% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.14% |
| 6 | NEW YORK STATE COMMON RETIREMENT FUND | 1.65% |
| 7 | Charles Schwab | 0.86% |
| 8 | Northern Trust | 0.73% |
| 9 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.59% |
| 10 | MELLON INVESTMENTS Corp | 0.58% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with BlackRock, Inc. | 18,482,795 | 14.59% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| BlackRock | 18,069,282 | 14.27% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with The Vanguard Group | 11,890,700 | 9.39% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Vanguard Group | 9,622,008 | 7.60% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with Brown Capital Management, LLC | 9,493,474 | 7.50% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Millennium Management LLC | 7,872,900 | 6.22% | Schedule 13G, filed May 18, 2026 |
| Topline Capital Management, LLC | 6,780,847 | 5.35% | Schedule 13G, filed November 17, 2025 |
| Entities affiliated with Hillhouse Investment Management, Ltd. | 6,657,030 | 5.26% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Ming Yan, Ph.D. | 6,363,586 | 5.02% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Wenbin Jiang, Ph.D. | 6,094,266 | 4.81% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
Percentages above are of 126,659,196 shares outstanding, as reported by CYTEK BIOSCIENCES INC. on its Form 10-Q dated April 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CYTEK BIOSCIENCES INC.'s shareholder meeting held June 18, 2025, in the 2024-2025 proxy season, 164 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 893 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS… — CYTEK BIOSCIENCES INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CYTEK BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTEK BIOSCIENCES INC.’s 10-Q dated April 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CYTEK BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “CYTEK BIOSCIENCES (CTKB) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cytek-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.